Conversion to monotherapy: Clinical trials in patients with refractory partial seizures

Neurology

Volumn 60, Issue 11 SUPPL. 4, 2003, Pages

  Beydoun, Ahmad ^a   Kutluay, Ekrem ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID;

CLINICAL TRIAL; COMPLEX PARTIAL SEIZURE; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; EPILEPSY; FOCAL EPILEPSY; GRAND MAL EPILEPSY; HUMAN; MONOTHERAPY; OUTCOMES RESEARCH; OUTPATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; SIMPLE PARTIAL SEIZURE;

EID: 0038340915     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.60.11_suppl_4.s13     Document Type: Review

References (25)

1. Beydoun A. Monotherapy trials of new antiepileptic drugs. Epilepsia 1997;38(suppl 9):S21-31.
2. Perucca E. Evaluation of drug treatment outcome in epilepsy: a clinical perspective. Pharm World Sci 1997;19:217-222.
3. French JA. What trials, which designs? Epilepsia 1997;38:263-265.
4. Beydoun A. Legal aspects of antiepileptic drug development. In: Bruni J, ed. Legal Issues in Epilepsy Handbook. Toronto: The Medicine Group, 1998:19-23.
5. Cereghino JJ. Clinical trial design for antiepileptic drugs. Ann Neurol 1992;32:393-394.
6. Pledger GW, Kramer LD. Clinical trials of investigational antiepileptic drugs: monotherapy designs. Epilepsia 1991;32:716-721.
7. Sachdeo R, Kramer LD, Rosenberg A, et al. Felbamate monotherapy: controlled trial in patients with partial-onset seizures. Ann Neurol 1992;32:386-392.
8. Faught E, Sachdeo RC, Remler MP, et al. Felbamate monotherapy for partial-onset seizures: an active-control trial. Neurology 1993;43:688-692.
9. Devinsky O, Faught RE, Wilder BJ, et al. Efficacy of felbamate monotherapy in patients undergoing presurgical evaluation of partial seizures. Epilepsy Res 1995;20:241-246.
10. Theodore WH, Albert P, Stertz B, et al. Felbamate monotherapy: implications for antiepileptic drug development. Epilepsia 1995;36:1105-1110.
11. Beydoun A, Fischer J, Labar DR, et al. Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83. Neurology 1997;49:746-752.
12. Sachdeo RC, Reife RA, Lim P, et al. Topiramate monotherapy for partial-onset seizures. Epilepsia 1997;38:294-300.
13. Schachter SC. Tiagabine monotherapy in the treatment of partial epilepsy. Epilepsia 1995;36(suppl 6):S2-6.
14. Gilliam F, Vazquez B, Sackellares JC, et al. An active-control of lamotrigine monotherapy for partial seizures. Neurology 1998;51:1018-1025.
15. Beydoun A, Sachdeo RC, D'Souza J, et al. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial. Neurology 2000;54:2245-2251.
16. Sachdeo R, Beydoun A, D'Souza J, et al. Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures. Neurology 2001;57:864-871.
17. Beydoun A, Milling CJ. Active-control comparative equivalency monotherapy trials in epilepsy: are they scientifically valid? Epilepsy Behav 2001;2:187-192.
18. Temple R, Ellenberg SS. Placebo-controlled trials and active-control trials in the evaluation of new treatment: part 1. Ethical and scientific issues. Ann Intern Med 2000;133:455-456.
19. World Medical Association. Declararion of Helsinki (as revised). www.wma.net/e/policy/17-c_e.html (accessed February 8, 2003).
20. Lewis JA, Johnson B, Kreutz G, Sampaio C, van Zwieten-Boot B. Placebo-controlled trials and Declaration of Helsinki. Lancet 2002;359: 1337-1340.
21. Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med 1994;331:394-398.
22. Bergey GK, Morris HH, Pierce M, et al. Gabapentin monotherapy: I. An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. Neurology 1997;49:739-745.
23. Schachter SC, Vazquez B, Kramer L, et al. Oxcarbazepine: doubleblind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology 1999;52:732-737.
24. Abu-Khalil BW, Vazquez BR, Beydoun AA, et al. Pregabalin in-patient monotherapy trial - study results and impact of seizure frequency on efficacy evaluations. Epilepsia 1999;40(suppl 7):109. Abstract.
25. Alarcon G, Binnie CD, Elwes RDC, Polkey CE. Monotherapy antiepileptic drug trials in patients undergoing presurgical assessment: methodological problems and possibilities. Seizures 1995;4:293-301.